Crossmark

m6A methylation-modified ETV1 drives multiple myeloma progression and M2 polarization of tumor-associated macrophage through transcriptional activation of RBMS1

Crossref DOI link: https://doi.org/10.1186/s12967-026-07799-7

Published Online: 2026-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yan

Geng, Yueqi

Zheng, Boyang

Zhang, Aijia

Yang, Kerou

Mao, Yinling

Jiang, Li https://orcid.org/0009-0004-0470-2437
Funding

Funding for this research was provided by:

Natural Science Foundation of Heilongjiang Province (PL2024H160)

XinRui Cancer Support Treatment Project of China Primary Health Care Foundation (cphcf-2022-226)

Haiyan Foundation of Harbin Medical University Cancer Hospital (JJMS2021-28)
License Information

Text and Data Mining valid from 2026-02-13

Version of Record valid from 2026-03-20
More Information

Article History

Received: 25 November 2025

Accepted: 23 January 2026

First Online: 13 February 2026

Declarations

:

: All animal procedures were approved by the Ethics Committee of the Harbin Medical University and were conducted in accordance with the Guide for the Care and Use of Laboratory Animals.

: The authors declare no potential conflicts of interest.

Document is current

Any future updates will be listed below